Roche’s experimental enicepatide reduced weight without a plateau through week 48 while also improving blood sugar in adults with diabetes and obesity.
This website uses cookies to improve your web experience.
Roche’s experimental enicepatide reduced weight without a plateau through week 48 while also improving blood sugar in adults with diabetes and obesity.
Adding {{itemName}} to cart
Added {{itemName}} to cart